In addition, Benetti et al. also documented the inhibitory effects of empagliflozin upon the NLRP3 inflammasome and the subsequent mitigation of inflammatory responses in DKD in a mouse model of a high-fat, high-sugar diet [66]. This evidence concerns the gene NLRP3 and diabetic kidney disease.